| scholarly article | Q13442814 |
| P50 | author | Tao Wen | Q64913488 |
| P2093 | author name string | Lei Yang | |
| Jian Liu | |||
| Haili Qian | |||
| Zhe Liu | |||
| Feng Xu | |||
| Guangyu An | |||
| Yuliang Jiang | |||
| Xingyuan Jia | |||
| Tianbo Gao | |||
| Xichen Dong | |||
| Yurong Cheng | |||
| Yizhang Hu | |||
| P2860 | cites work | Cloning and expression of human core 1 beta1,3-galactosyltransferase | Q24291836 |
| Molecular cloning and characterization of a novel UDP-GlcNAc:GalNAc-peptide beta1,3-N-acetylglucosaminyltransferase (beta 3Gn-T6), an enzyme synthesizing the core 3 structure of O-glycans | Q24292241 | ||
| Loss of intestinal core 1-derived O-glycans causes spontaneous colitis in mice | Q24295254 | ||
| A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase | Q24543917 | ||
| Mucins in cancer: function, prognosis and therapy | Q24633765 | ||
| Roles of the gel-forming MUC2 mucin and its O-glycosylation in the protection against colitis and colorectal cancer | Q26995226 | ||
| A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V | Q28294206 | ||
| Cosmc is an essential chaperone for correct protein O-glycosylation | Q28506209 | ||
| Colorectal cancer in mice genetically deficient in the mucin Muc2 | Q28588769 | ||
| The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions | Q29617847 | ||
| Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection | Q29618129 | ||
| Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa | Q33582232 | ||
| The endoplasmic reticulum chaperone Cosmc directly promotes in vitro folding of T-synthase | Q33593911 | ||
| Mucin 2 silencing promotes colon cancer metastasis through interleukin-6 signaling. | Q33918398 | ||
| Core 3 synthase is down-regulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells. | Q33934190 | ||
| Mutations in APC, Kirsten-ras, and p53--alternative genetic pathways to colorectal cancer. | Q34035601 | ||
| Immature truncated O-glycophenotype of cancer directly induces oncogenic features | Q34314283 | ||
| A novel fluorescent assay for T-synthase activity | Q34552242 | ||
| Colorectal cancer statistics, 2017. | Q34552373 | ||
| NF-kappaB protects human papillomavirus type 38 E6/E7-immortalized human keratinocytes against tumor necrosis factor alpha and UV-mediated apoptosis. | Q35193057 | ||
| Increased activity of cell surface peptidases in HeLa cells undergoing UV-induced apoptosis is not mediated by caspase 3. | Q35865937 | ||
| Defective Intestinal Mucin-Type O-Glycosylation Causes Spontaneous Colitis-Associated Cancer in Mice | Q35983991 | ||
| Increased susceptibility to colitis and colorectal tumors in mice lacking core 3-derived O-glycans | Q36229430 | ||
| Epigenetic silencing of the chaperone Cosmc in human leukocytes expressing tn antigen | Q36436153 | ||
| Initiation of GalNAc-type O-glycosylation in the endoplasmic reticulum promotes cancer cell invasiveness. | Q37117895 | ||
| Loss of intestinal O-glycans promotes spontaneous duodenal tumors | Q37139510 | ||
| Carbohydrate markers in colon carcinoma | Q37363702 | ||
| Cosmc is an X-linked inflammatory bowel disease risk gene that spatially regulates gut microbiota and contributes to sex-specific risk. | Q37534378 | ||
| Blood group A cross-reacting epitope defined by monoclonal antibodies NCC-LU-35 and -81 expressed in cancer of blood group O or B individuals: its identification as Tn antigen | Q37552405 | ||
| The Tn antigen-structural simplicity and biological complexity | Q37831859 | ||
| The Cosmc connection to the Tn antigen in cancer | Q38197051 | ||
| Glycosylation in cancer: mechanisms and clinical implications | Q38569702 | ||
| COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer. | Q38869978 | ||
| Cancer Statistics, 2017. | Q39038674 | ||
| Regulation of O-glycosylation through Golgi-to-ER relocation of initiation enzymes | Q39700918 | ||
| Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc | Q40002603 | ||
| Cancer statistics in China, 2015. | Q40064386 | ||
| A mutant chaperone converts a wild-type protein into a tumor-specific antigen | Q40220542 | ||
| The molecular chaperone Cosmc enhances malignant behaviors of colon cancer cells via activation of Akt and ERK. | Q44392892 | ||
| Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer | Q44572570 | ||
| Protein glycosylation: chaperone mutation in Tn syndrome | Q46776454 | ||
| Expression of Tn, sialosyl Tn, and T antigens in human pancreas | Q46842675 | ||
| Targeted disruption of the gene encoding core 1 beta1-3-galactosyltransferase (T-synthase) causes embryonic lethality and defective angiogenesis in mice | Q48365705 | ||
| ST6GalNAc-I controls expression of sialyl-Tn antigen in gastrointestinal tissues. | Q51767552 | ||
| Carbohydrate expression profile of colorectal cancer cells is relevant to metastatic pattern and prognosis. | Q52842975 | ||
| Helix pomatia agglutinin binding is a useful prognostic indicator in colorectal carcinoma | Q57222452 | ||
| O-linked mucin-type glycoproteins in normal and malignant colon mucosa: lack of T-antigen expression and accumulation of Tn and sialosyl-Tn antigens in carcinomas | Q68749979 | ||
| Blood group MN specific substances and precursors in normal and malignant human breast tissues | Q68802187 | ||
| Tn, a carcinoma-associated antigen, reacts with anti-Tn of normal human sera | Q70077073 | ||
| Mucin carbohydrate antigens (T, Tn, and sialyl-Tn) in human ovarian carcinomas: relationship with histopathology and prognosis | Q73622361 | ||
| Expression of sialyl-Tn, Tn and T antigens in primary liver cancer | Q77872186 | ||
| P433 | issue | 10 | |
| P921 | main subject | colorectal cancer | Q188874 |
| colorectal carcinoma | Q25493920 | ||
| P304 | page(s) | 4875-4885 | |
| P577 | publication date | 2018-07-12 | |
| P1433 | published in | Journal of Cellular and Molecular Medicine | Q1524063 |
| P1476 | title | Aberrant O-glycosylation contributes to tumorigenesis in human colorectal cancer | |
| P478 | volume | 22 |
| Q89782685 | A Systematic Review on the Implications of O-linked Glycan Branching and Truncating Enzymes on Cancer Progression and Metastasis |
| Q98224783 | Altered Glycosylation Contributes to Placental Dysfunction Upon Early Disruption of the NK Cell-DC Dynamics |
| Q90217150 | Cosmc Disruption-Mediated Aberrant O-glycosylation Suppresses Breast Cancer Cell Growth via Impairment of CD44 |
| Q89908247 | Demethylation of the Cosmc Promoter Alleviates the Progression of Breast Cancer Through Downregulation of the Tn and Sialyl-Tn Antigens |
| Q95839861 | Overexpression of Cosmc suppresses cell migration and invasion in different subtypes of breast cancer cells via Tn and T glycans |
| Q64249139 | Tn antigen promotes human colorectal cancer metastasis via H-Ras mediated epithelial-mesenchymal transition activation |
Search more.